Gorsuch Dissents: The Justice Who Refused to Pick a Side

Neil Gorsuch wrote a dissent in the birthright ruling that managed to alienate both the Trump administration and the court's liberal bloc simultaneously. That is not an accident. That is a man who has decided he answers to neither team — and is comfortable with what that costs him.

Let me tell you what that dissent actually means, because the coverage has been focused on the wrong thing.

Everyone is treating Gorsuch's position as ideologically confusing. It isn't. It is jurisprudentially consistent in a way that makes it more dangerous to the current administration than a straightforward liberal dissent would have been. A liberal dissent is expected, filed, and forgotten. A conservative justice — appointed by Trump, confirmed by a Republican Senate — writing separately to say that the executive branch exceeded its authority creates a paper trail that no administration wants in its archive. It becomes precedent for the next case. And the case after that.

This is the architecture of long-game jurisprudence. Gorsuch is not playing the news cycle. He is placing stones on a board that most people haven't looked at yet.

Now bring this closer to home, because the principle at stake matters well beyond American constitutional law. The question underneath the birthright dispute — how far can executive authority reach before courts intervene — is one that Malta and EU institutions wrestle with in a different register, constantly. Regulatory bodies issuing administrative decisions that effectively override statutory rights. Government agencies making determinations with legal consequences but without the procedural safeguards a court would require. The executive reaching into territory that the legislature never explicitly handed it.

The Maltese Administrative Review Tribunal exists precisely because of this tension. So does the EU's principle of proportionality — the doctrine that says an authority's action must be proportionate to its legitimate aim, no more. When a Maltese employer dismisses a worker under a contractual clause drafted to look legal while functioning as a penalty, that is executive overreach wearing a private contract's clothing. When a landlord issues a notice designed to intimidate a tenant into vacating a property before the tenant has had a chance to understand their Industrial Tribunal rights, that is the same architecture in a smaller room.

What Gorsuch understood — and what the coverage missed — is that the cleanest legal victories are the ones that don't announce themselves as victories. A dissent that says "I agree the executive lost, but not for the reasons you think, and here is the reason that will matter next time" is not a loss for anyone except the people who needed a clean narrative. Clean narratives are for press releases. Courts run on precedent.

I once sat across a table from a developer's solicitor — seven floors of offices, three partners billing by the six-minute unit — while we discussed a tenant client who had received a notice she didn't understand and couldn't afford to challenge. The solicitor was confident. Polite, but confident. He had the paper. He had the clause. He had the leverage. What he didn't have was patience, because his client needed the property cleared by a deadline. I had patience. I filed nothing. I sent one letter — not to the solicitor, to the developer's board directly — that outlined, calmly, what the Industrial Tribunal process looked like and approximately how long it would take if we decided to use it. We settled in four days. The tenant stayed. No gavel was ever raised.

That is the Gorsuch move, translated into practical terms. You don't always win by winning the current argument. You win by making clear that the next argument is one the other side cannot afford to have.

The Roundup ruling from the Supreme Court this week follows the same logic at mass-tort scale. By siding with Monsanto on the preemption question, the Court has effectively placed thousands of individual plaintiffs in limbo — their cases stalled, their path to remedy narrowed, the litigation strategy of their counsel now requiring a full reset. What seemed like a clear factual case — product causes harm, manufacturer knew — runs into a federal preemption wall that says: if the regulator approved the label, the state court cannot second-guess it. That wall is not impenetrable. But it requires a different approach than the one those plaintiffs' lawyers were using.

The lesson is the same one it always is: the written side of the agreement is never the whole agreement. The regulatory approval is never the full story. The label is not the liability. And the question you ask last — what aren't they telling me — is always the one that opens the room.

**